Product How it works Pricing Blog FAQ About Contact
PTC Therapeutics

PTC Therapeutics (NASDAQ: PTCT) revenue

PTC Therapeutics reported revenue of $1,731m for fiscal 2025, 114.5% more than in fiscal 2024 ($806.8m). Since fiscal 2016 its revenue has grown by 1,992.6%, an average growth of 40.2% a year.

Fiscal 2025 is the highest of the 10 fiscal years on record for PTC Therapeutics. The biggest drop was in fiscal 2024, −14.0%.

Revenue, in millions of US dollars82.72016194.42017264.72018307.02019380.82020538.62021698.82022937.82023806.820241,7312025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$1,731m+114.5%$866.9m50.1%
2024$806.8m−14.0%−$302.6m−37.5%
2023$937.8m+34.2%−$439.5m−46.9%
2022$698.8m+29.7%−$447.4m−64.0%
2021$538.6m+41.4%−$374.4m−69.5%
2020$380.8m+24.0%−$431.8m−113.4%
2019$307.0m+16.0%−$241.2m−78.6%
2018$264.7m+36.2%−$115.7m−43.7%
2017$194.4m+135.0%−$64.3m−33.1%
2016$82.7m—−$132.1m−159.7%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

PTC Therapeutics revenue compared with its sector

By revenue for its latest fiscal year, PTC Therapeutics ranks 121st of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; PTC Therapeutics, 114.5%.

RankCompanyRevenueRevenue growth
119thInteger$1,854m8.0%
120thHealthcare Services Group$1,837m7.1%
121stPTC Therapeutics$1,731m114.5%
122ndIntegra Lifesciences$1,635m1.5%
123rdLantheus$1,542m0.5%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of PTC Therapeutics

How much revenue did PTC Therapeutics make in fiscal 2025?
PTC Therapeutics reported revenue of $1,731m for fiscal 2025, compared with $806.8m in fiscal 2024.
How much has the revenue of PTC Therapeutics grown?
Between fiscal 2016 and fiscal 2025 it went from $82.7m to $1,731m: 1,992.6% more, an average growth of 40.2% a year.
What was the best year for revenue at PTC Therapeutics?
Of its last 10 fiscal years, fiscal 2025, with $1,731m.
Where does PTC Therapeutics rank in its sector by revenue?
It ranks 121st of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for PTC Therapeutics come from?
From the annual report (Form 10-K) that PTC Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that PTC Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on PTC Therapeutics: the PTC Therapeutics page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.